Market Entry Sprint
Six to ten weeks. Single US category, single corridor. The firm rebuilds positioning, pricing posture, messaging, and trust architecture for the American buyer, then launches it into market.
See the Sprint →
US market architecture for operators from Belgium, the Netherlands, and Luxembourg. Brussels EU-institutional, Antwerp chemicals and diamonds, Belgian biotech, Dutch industrials and tech, and Luxembourg fund-services each carry distinct US-translation requirements. The language is not the gap.
The Benelux gate covers Amsterdam and Luxembourg City as Phase 1 city-level deep dives. Brussels and Rotterdam are future Phase 2 city-gate candidates as demand surfaces. Operators routing through a German parent can also reference the DACH market gate.
Benelux operators are typically Anglophone-fluent and process-led. The team speaks excellent English. The materials read fluently. The product is well-documented. American buyers respond warmly on the first call and quietly slow the engagement. The fluency is not the gap. The structural register is. Brussels EU-institutional commercial services arrive at US procurement with materials calibrated to EU institutional buyers and read in the United States as policy-adjacent rather than as commercial. The American buyer is filtering on category anchor, outcome claim, US peer set, and past-performance evidence in US-recognised commercial structures. EU-institutional positioning reads as adjacent to that frame rather than inside it.
Antwerp chemicals and diamonds operate in US-recognised supply chains but typically lead with European and African past-performance and read as European-anchored rather than as US-applicable. Belgian biotech reads as research-led and pre-commercial when the American payer and hospital-system buyer is filtering on US clinical-evidence and US procurement-readiness. Dutch fintech and tech have already crossed and built strong US presence (Adyen as the canonical example); the operator pattern for Dutch industrials, Dutch agri-tech, and Belgian biotech entering US is the higher-friction segment. Luxembourg fund-services reads as fiduciary-corridor language to a US institutional buyer who is filtering on US distribution structure rather than on UCITS or AIFMD framing. Pricing in EUR, ranges, and starting-from figures reads as soft and negotiable. American buyers expect firm pricing in dollars and a clean US category anchor before they interpret the price.
The Benelux operator walks into the US assuming Anglophone fluency closes the gap. The fluency is the camouflage. The gap sits in the US category, the US peer set, and the US-procurement-shaped outcome claim. House view on Benelux entry
Six to ten weeks. Single US category, single corridor. The firm rebuilds positioning, pricing posture, messaging, and trust architecture for the American buyer, then launches it into market.
See the Sprint →Three to six months. Multi-channel US rebuild and run. Paid, owned, earned, conversion architecture, sales enablement. The standard shape for Benelux operators committed to serious US scale.
See the Build →Monthly retainer, twelve-month minimum. Ongoing rebuild-and-run across multiple US surfaces. Typical for Benelux-headquartered groups with several US-facing brands and for Luxembourg fund-services platforms with US institutional channels.
See the Partnership →City-specific deep dives: Amsterdam · Luxembourg City · reference frames: operator pattern for US entry.
No legal services. No Benelux company formation, no FSMA, AFM, CSSF, or adjacent regulator filings, no US entity formation. No L-1, E-2, EB-5, or O-1 visa work. No US tax structuring, FATCA analysis, or double-tax-treaty analysis. No customs and tariff classification. No US banking introductions. No fiduciary services. No regulatory licensing. No IP filing. No contract drafting. No FDA, FCC, or DOT clearance work for life-sciences, electronics, or hardware operators. No UCITS, AIFMD, or US-distribution structuring for Luxembourg fund-services operators.
These sit with Belgian, Dutch, and Luxembourg counsel who specialise in US entry, and with US counsel on the American side. The firm works inside the parameters they set. When a marketing decision carries legal or tax implications, the firm flags it and defers before execution.
Anglophone fluency is not the gap. The structural register is. Benelux materials are typically process-led, EU-institutional, or research-led, and read in the United States as policy-adjacent, European-anchored, or pre-commercial rather than as US-procurement-shaped. American buyers filter on category anchor, outcome claim, US peer set, and past-performance evidence in US-recognised commercial structures. The fluency closes the language gap and exposes the structural register gap.
Adyen, Booking, Elastic, MessageBird, and Mollie built US-facing positioning at category-level conviction and benefited from a category vanguard that the next-tier Dutch fintech operator can follow. Dutch industrials, Dutch agri-tech, and Belgian biotech do not yet carry that vanguard. The fix is the same US-frame translation work, applied to industries that have not yet had a category lead-out.
No. US entity formation, E-2 and L-1 visa work, UCITS and AIFMD structuring, US-distribution work for fund-services operators, double-tax-treaty analysis, and banking introductions sit with the operator's own counsel. The firm designs US marketing architecture inside the legal and tax structure counsel has already established.
EU-institutional commercial services, Antwerp chemicals and diamonds, Belgian biotech and industrials, Dutch fintech and tech, Dutch agri-tech and maritime infrastructure, Luxembourg fund-services and fiduciaries, and Benelux family-office-backed portfolios. Fit is confirmed in discovery, not in published sector lists.
Amsterdam and Luxembourg City have dedicated city-level pages at /cities/amsterdam/ and /cities/luxembourg-city/. Brussels and Rotterdam are future Phase 2 city-gate candidates as demand surfaces. The Benelux gate carries the cross-region work for those operators today.